SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001610717-24-000415
Filing Date
2024-08-07
Accepted
2024-08-07 17:34:18
Documents
2
Period of Report
2024-08-05

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1358
2 poa.htm EX-24 7820
  Complete submission text file 0001610717-24-000415.txt   10556
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Clyburn Frank (Reporting) CIK: 0001763963 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39219 | Film No.: 241185200